Candida albicans FKS1 beta-1,3-glucan with mutations conferring resistance to fluconazole

Ontology CARD's Antibiotic Resistance Ontology
Accession ARO:3009559
DefinitionIn Candida albicans, FKS1 encodes a catalytic subunit of the beta-1,3-D-glucan synthase complex typically associated with resistance to echinocandin antifungals. Although azoles primarily target ergosterol biosynthesis, rare FKS1 mutations have been reported to confer resistance. These mutations are thought to alter cell wall integrity and membrane to cell wall interactions, triggering compensatory stress response pathways that indirectly mitigate azole-mediated growth inhibition. Such cases represent uncommon, context-dependent resistance mechanisms rather than direct target-site resistance.
AMR Gene Familyazole resistant beta-1,3-glucan synthase
Drug Classazole antibiotic, triazole antifungal
Resistance Mechanismantibiotic target alteration
Classification12 ontology terms | Show
Parent Term(s)3 ontology terms | Show
+ confers_resistance_to_antibiotic fluconazole [Antibiotic]
+ derives_from antifungal-susceptible beta-1,3-glucan synthase
+ azole resistant beta-1,3-glucan synthase [AMR Gene Family]
Publications

Bédard C, et al. 2025. Nat Microbiol : FungAMR: a comprehensive database for investigating fungal mutations associated with antimicrobial resistance. (PMID 40790106)

Private model - RGI is not currently using this model.

Curator Acknowledgements
Curator Description Most Recent Edit